With 1.33 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.93 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $0.87736 whereas the lowest price it dropped to was $0.81. The 52-week range on DNMR shows that it touched its highest point at $3.56 and its lowest point at $0.60 during that stretch. It currently has a 1-year price target of $1.51. Beta for the stock currently stands at 1.62.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DNMR was up-trending over the past week, with a rise of 9.33%, but this was down by -21.90% over a month. Three-month performance surged to 26.15% while six-month performance fell -50.00%. The stock lost -75.00% in the past year, while it has lost -19.61% so far this year. A look at the trailing 12-month EPS for DNMR yields -1.52 with Next year EPS estimates of -0.52. For the next quarter, that number is -0.23. This implies an EPS growth rate of 42.60% for this year and 40.16% for next year.
Float and Shares Shorts:
At present, 102.83 million DNMR shares are outstanding with a float of 101.72 million shares on hand for trading. On 2024-04-15, short shares totaled 22.0 million, which was 1925.9999999999998 higher than short shares on 1710460800. In addition to Mr. Stephen E. Croskrey as the firm’s CEO & Chairman of the Board, Mr. Michael A. Hajost serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.40542 of DNMR’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2023-12-31, DNMR reported revenue of $10945000.0 and operating income of -$30832000.0. The EBITDA in the recently reported quarter was -$23409000.0 and diluted EPS was $nan.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DNMR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
